Clinical trial: DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study (NCT02379507)

Eligibility criteria:
Inclusion Criteria:

          -  Healthy male or female ≥ 18 and ≤ 70 years of age.

          -  Body mass index (BMI) ≥ 20 and ≤ 35 kg/m2.

          -  Subjects with mild to moderate eczema; determined at screening visit.

          -  Judged by the Investigator to be in general good health on the basis of medical
             history.

          -  Agree to use the Study-supplied cleanser and moisturizer as the only body cosmetic
             applied to irritated skin.

          -  Agree to stop all medications and supplements during the entire length of the study

          -  Females of child bearing potential must agree to use appropriate birth control methods
             during the entire study period.

          -  Agree not to initiate any new exercise or diet programs during the entire study
             period.

          -  Agree not to change their current diet or exercise program during the entire study
             period.

          -  Understands the study procedures and signs forms providing informed consent to
             participate in the study and authorization for release of relevant protected health
             information to the study investigator.

        Exclusion Criteria:

          -  Clinically significant renal, hepatic, endocrine (including diabetes mellitus),
             cardiac, pulmonary, pancreatic, neurologic, hematologic, or biliary disorder.

          -  Known allergy or sensitivity to Herbal products.

          -  History or presence of cancer in the prior two years, including any skin cancer or
             suspicious lesions.

          -  Recent history of alcoholism (within 12 months) or strong potential for alcohol or
             substance abuse.

          -  Participation in a clinical study with exposure to any non-registered drug product
             within 30 days prior.

          -  Individual has a condition the Investigator believes would interfere with his or her
             ability to provide informed consent, comply with the study protocol, which might
             confound the interpretation of the study results or put the person at undue risk.
             Including subjects who are Bed or wheelchair-bound.

          -  Pregnant, lactating, or unwilling to use adequate contraception during the duration of
             the study.

          -  Smoking - must be nonsmoker for at least 12 weeks prior to screening.
No condition on gender to be admitted to the trial.
Accepts Healthy Volunteers
Subject must be at least 18 Years old.
Subject must be at most 70 Years

Patient description (medical language): A 2-year-old boy is brought to the office by his parents due to a rash that started 1 week ago.  A similar red, itchy rash on the cheeks, trunk, and arms has occurred intermittently since infancy.  The patient has had a few upper respiratory infections but no major illnesses.  Vaccinations are up to date, and he takes no medications. He is on a balanced diet, and he is healthy in appearance.  Vital signs and milestone examination are within normal limits.  Similar findings are observed on the cheeks and proximal upper extremities.  The diaper area is clear, and no mucosal lesions are present.

Patient description (patient's own words): I just brought my two-year-old son to the doctor's office because he had a rash for like one week. His rash was on the cheeks, the trunk, and his arms. He already had this before, and it keeps coming back from time to time to time. In the past, he had some respiratory infections but he has never been this sick. His vaccinations are up to date, and he doesn't take any medication. He's healthy with a nice diet. The doctor told me his vitals and milestone examinations were normal. The doctor also said there was a rash around the cheek and the upper part of his arms. The diaper area is okay, and there are no lesions.

Does the patient match the trial criteria? 0